?

Less Ads, More News – YBH!
Saturday May 18th 2013
World News Map

Elan offers Tysabri dividend after Royalty approach

Share in an emailShare on FacebookShare on TwitterShare on Stumble UponShare on RedditShare on DiggSubscribe to Yes, But, However!Print this articleybh spacer

DUBLIN (Reuters) – Irish drugmaker Elan said it will give shareholders 20 percent of the royalty rights for multiple sclerosis drug Tysabri in a bid to stave off an approach for the company by U.S. investment firm Royalty Pharma .

Read More

article archive.

Post Published: 04 March 2013
Found in section: Finance